218 related articles for article (PubMed ID: 30252466)
21. Identifying key amino acid residues that affect α-conotoxin AuIB inhibition of α3β4 nicotinic acetylcholine receptors.
Grishin AA; Cuny H; Hung A; Clark RJ; Brust A; Akondi K; Alewood PF; Craik DJ; Adams DJ
J Biol Chem; 2013 Nov; 288(48):34428-42. PubMed ID: 24100032
[TBL] [Abstract][Full Text] [Related]
22. Stoichiometry dependent inhibition of rat α3β4 nicotinic acetylcholine receptor by the ribbon isomer of α-conotoxin AuIB.
Wu X; Tae HS; Huang YH; Adams DJ; Craik DJ; Kaas Q
Biochem Pharmacol; 2018 Sep; 155():288-297. PubMed ID: 30009767
[TBL] [Abstract][Full Text] [Related]
23. The Structural Features of α-Conotoxin Specifically Target Different Isoforms of Nicotinic Acetylcholine Receptors.
Wu RJ; Wang L; Xiang H
Curr Top Med Chem; 2015; 16(2):156-69. PubMed ID: 26126912
[TBL] [Abstract][Full Text] [Related]
24. Potency- and Selectivity-Enhancing Mutations of Conotoxins for Nicotinic Acetylcholine Receptors Can Be Predicted Using Accurate Free-Energy Calculations.
Katz D; DiMattia MA; Sindhikara D; Li H; Abraham N; Leffler AE
Mar Drugs; 2021 Jun; 19(7):. PubMed ID: 34202022
[TBL] [Abstract][Full Text] [Related]
25. Molecular Determinants of Species Specificity of α-Conotoxin TxIB towards Rat and Human α6/α3β4 Nicotinic Acetylcholine Receptors.
Xie T; Qin Y; Zhao J; Dong J; Qi P; Zhang P; Zhangsun D; Zhu X; Yu J; Luo S
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37239959
[TBL] [Abstract][Full Text] [Related]
26. Rational design of alpha-conotoxin analogues targeting alpha7 nicotinic acetylcholine receptors: improved antagonistic activity by incorporation of proline derivatives.
Armishaw C; Jensen AA; Balle T; Clark RJ; Harpsøe K; Skonberg C; Liljefors T; Strømgaard K
J Biol Chem; 2009 Apr; 284(14):9498-512. PubMed ID: 19131337
[TBL] [Abstract][Full Text] [Related]
27. Structural and Functional Characterization of a Novel α-Conotoxin Mr1.7 from Conus marmoreus Targeting Neuronal nAChR α3β2, α9α10 and α6/α3β2β3 Subtypes.
Wang S; Zhao C; Liu Z; Wang X; Liu N; Du W; Dai Q
Mar Drugs; 2015 May; 13(6):3259-75. PubMed ID: 26023835
[TBL] [Abstract][Full Text] [Related]
28. A Novel α4/7-Conotoxin QuIA Selectively Inhibits α3β2 and α6/α3β4 Nicotinic Acetylcholine Receptor Subtypes with High Efficacy.
Wang L; Wu X; Zhu X; Zhangsun D; Wu Y; Luo S
Mar Drugs; 2022 Feb; 20(2):. PubMed ID: 35200675
[TBL] [Abstract][Full Text] [Related]
29. Design and synthesis of α-conotoxin GID analogues as selective α4β2 nicotinic acetylcholine receptor antagonists.
Banerjee J; Yongye AB; Chang YP; Gyanda R; Medina-Franco JL; Armishaw CJ
Biopolymers; 2014 Jan; 102(1):78-87. PubMed ID: 24122487
[TBL] [Abstract][Full Text] [Related]
30. RegIIA: an α4/7-conotoxin from the venom of Conus regius that potently blocks α3β4 nAChRs.
Franco A; Kompella SN; Akondi KB; Melaun C; Daly NL; Luetje CW; Alewood PF; Craik DJ; Adams DJ; Marí F
Biochem Pharmacol; 2012 Feb; 83(3):419-26. PubMed ID: 22108175
[TBL] [Abstract][Full Text] [Related]
31. Single amino acid substitutions in alpha-conotoxin PnIA shift selectivity for subtypes of the mammalian neuronal nicotinic acetylcholine receptor.
Hogg RC; Miranda LP; Craik DJ; Lewis RJ; Alewood PF; Adams DJ
J Biol Chem; 1999 Dec; 274(51):36559-64. PubMed ID: 10593955
[TBL] [Abstract][Full Text] [Related]
32. α-Conotoxin PeIA[S9H,V10A,E14N] potently and selectively blocks α6β2β3 versus α6β4 nicotinic acetylcholine receptors.
Hone AJ; Scadden M; Gajewiak J; Christensen S; Lindstrom J; McIntosh JM
Mol Pharmacol; 2012 Nov; 82(5):972-82. PubMed ID: 22914547
[TBL] [Abstract][Full Text] [Related]
33. Basic Residues at Position 11 of α-Conotoxin LvIA Influence Subtype Selectivity between α3β2 and α3β4 Nicotinic Receptors via an Electrostatic Mechanism.
Haufe Y; Kuruva V; Samanani Z; Lokaj G; Kamnesky G; Shadamarshan P; Shahoei R; Katz D; Sampson JM; Pusch M; Brik A; Nicke A; Leffler AE
ACS Chem Neurosci; 2023 Dec; 14(24):4311-4322. PubMed ID: 38051211
[TBL] [Abstract][Full Text] [Related]
34. α-Conotoxin Bt1.8 from Conus betulinus selectively inhibits α6/α3β2β3 and α3β2 nicotinic acetylcholine receptor subtypes.
Ning H; Huang B; Tae HS; Liu Z; Yu S; Li L; Zhang L; Adams DJ; Guo C; Dai Q
J Neurochem; 2021 Oct; 159(1):90-100. PubMed ID: 34008858
[TBL] [Abstract][Full Text] [Related]
35. Alanine-Scanning Mutagenesis of α-Conotoxin GI Reveals the Residues Crucial for Activity at the Muscle Acetylcholine Receptor.
Ning J; Li R; Ren J; Zhangsun D; Zhu X; Wu Y; Luo S
Mar Drugs; 2018 Dec; 16(12):. PubMed ID: 30551685
[TBL] [Abstract][Full Text] [Related]
36. α-Conotoxins active at α3-containing nicotinic acetylcholine receptors and their molecular determinants for selective inhibition.
Cuny H; Yu R; Tae HS; Kompella SN; Adams DJ
Br J Pharmacol; 2018 Jun; 175(11):1855-1868. PubMed ID: 28477355
[TBL] [Abstract][Full Text] [Related]
37. Solving the alpha-conotoxin folding problem: efficient selenium-directed on-resin generation of more potent and stable nicotinic acetylcholine receptor antagonists.
Muttenthaler M; Nevin ST; Grishin AA; Ngo ST; Choy PT; Daly NL; Hu SH; Armishaw CJ; Wang CI; Lewis RJ; Martin JL; Noakes PG; Craik DJ; Adams DJ; Alewood PF
J Am Chem Soc; 2010 Mar; 132(10):3514-22. PubMed ID: 20163143
[TBL] [Abstract][Full Text] [Related]
38. α-Conotoxins Identify the α3β4* Subtype as the Predominant Nicotinic Acetylcholine Receptor Expressed in Human Adrenal Chromaffin Cells.
Hone AJ; McIntosh JM; Azam L; Lindstrom J; Lucero L; Whiteaker P; Passas J; Blázquez J; Albillos A
Mol Pharmacol; 2015 Nov; 88(5):881-93. PubMed ID: 26330550
[TBL] [Abstract][Full Text] [Related]
39. Identification of nicotinic acetylcholine receptor subunits in different lung cancer cell lines and the inhibitory effect of alpha-conotoxin TxID on lung cancer cell growth.
Qian J; Liu YQ; Sun ZH; Zhangsun DT; Luo SL
Eur J Pharmacol; 2019 Dec; 865():172674. PubMed ID: 31634461
[TBL] [Abstract][Full Text] [Related]
40. Analogs of alpha-conotoxin MII are selective for alpha6-containing nicotinic acetylcholine receptors.
McIntosh JM; Azam L; Staheli S; Dowell C; Lindstrom JM; Kuryatov A; Garrett JE; Marks MJ; Whiteaker P
Mol Pharmacol; 2004 Apr; 65(4):944-52. PubMed ID: 15044624
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
